Coronary and peripheral artery plaques: Do differences in plaque characteristics translate to differences in lipid management?

Medicine & Life Sciences

• Peripheral Arterial Disease 69%
• Coronary Vessels 51%
• Arteries 46%
• Lipids 41%
• Coronary Artery Disease 26%
• LDL Lipoproteins 24%
• Extremities 23%
• LDL Cholesterol 21%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 15%
• Risk Reduction Behavior 8%
• Lipoproteins 7%
• Quality of Health Care 6%
• Atherosclerosis 6%
• Triglycerides 6%
• Disease Progression 6%
• Quality of Life 5%
• Therapeutics 2%

Chemical Compounds

• Low-Density Lipoprotein Cholesterol 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 60%
• Lipid 43%
• Lipoprotein 23%
• Triglyceride 22%
• Reduction 9%